Is a pattern of increasing biomarker concentrations important for long-term risk stratification in acute coronary syndrome patients presenting early after the onset of symptoms?CLINICAL CHEMISTRYIF6.32008-04-0115OAAI
Upstream markers provide for early identification of patients at high risk for myocardial necrosis and adverse outcomesCLINICA CHIMICA ACTAIF2.92008-01-0116OAAI
Risk stratification for heart failure and death in an acute coronary syndrome population using inflammatory cytokines and N-terminal pro-brain natriuretic peptideCLINICAL CHEMISTRYIF6.32007-12-0159OAAI
Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocardial infarctionCLINICA CHIMICA ACTAIF2.92007-05-0150PREAI
Long-term health outcomes associated with detectable troponin I concentrationsCLINICAL CHEMISTRYIF6.32007-02-0166OAAI
Health outcomes categorized by current and previous definitions of acute myocardial infarction in an unselected cohort of troponin-naive emergency department patientsCLINICAL CHEMISTRYIF6.32006-11-0118OAAI
The. impact of the ESC/ACC redefinition of myocardial infarction and new sensitive troponin assays on the frequency of acute myocardial infarctionAMERICAN HEART JOURNALIF3.52006-07-0167PREAI